期刊文献+

结肠型克罗恩病手术治疗原则

Surgical strategy for colonic Crohn's disease
原文传递
导出
摘要 克罗恩病(Crohn’s disease,CD)临床表现复杂,目前尚无根治性的治疗方案。CD可发生于消化道任何部位,随着病情进展,可出现狭窄、梗阻、恶变、穿孔、瘘管等并发症,须及时外科干预。结肠型CD具有特有的临床表现及疾病转归,使其处理策略有别于其他部位的病变。正确把握手术时机并权衡手术利弊,选择合适手术时机及手术方式,在多学科综合治疗协作组模式下制定适合病人的个体化临床决策与方案,可使病人获益更多。 Clinical manifestations of Crohn’s disease(CD) varies from person to person. No curative treatment is available yet. CD occurs at any site of the GI tract. As the disease evolves, complications such as stricture, obstruction, malignant transformation, penetration and fistulas eventually occur, and surgery is demanded accordingly. With specific clinical features and prognosis of colonic CD, the therapeutic strategy is different from CD of other sites. Patients benefit more when pros and cons of the surgery are carefully weighed and when the surgery is performed in the appropriate approach at the right moment along with personalized therapy with multidisciplinary cooperation.
出处 《中国实用外科杂志》 CSCD 北大核心 2017年第3期232-235,共4页 Chinese Journal of Practical Surgery
关键词 克罗恩病 结肠 Crohn' s disease colon
  • 相关文献

参考文献2

二级参考文献14

  • 1吴晰,陆星华.我国克罗恩病患者临床表现分型的初步探讨[J].中华内科杂志,2006,45(8):661-663. 被引量:7
  • 2Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses Of Gastroenterology, Vienna 1998.Inflamm Bowel Dis, 2000,6:8-15.
  • 3Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol, 2005,19 (Suppl A): 5-36.
  • 4Ouyang Q, Tandon R, Goh KL,et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol, 2006, 21:1772-1782.
  • 5Leong RW, Lawranee IC, Ching JY, et al. Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients. Dig Dis Sci, 2004,49: 1672-1676.
  • 6Freeman HJ. Application of the Montreal classification for Crohnrs disease to a single clinician database of 1015 patients. Can J Gastroenterol, 2007,21 : 363-366.
  • 7Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut, 2001,49: 777-782.
  • 8Main J, McKenzie H, Yeaman GR, et al. Antibody to Saecharomyees cerevisiae (bakers' yeast) in Crohn's disease. BMJ, 1988, 297: 1105-1106.
  • 9Hisabe T, Matsui T, Sakurai T, et al. Anti Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol, 2003,38: 121-126.
  • 10Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn' s disease into immunologieally homogeneous subgroups with distinct clinical characteristics. Gut, 2000,47:487-496.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部